Oct 27, 2025 7:30 am EDT BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market
Oct 22, 2025 9:35 am EDT BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
Oct 6, 2025 2:28 pm EDT BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market
Aug 12, 2025 4:05 pm EDT BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
Aug 5, 2025 4:30 pm EDT BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
Jun 18, 2025 9:35 am EDT BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
Jun 13, 2025 7:45 am EDT BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease